Biostatistician Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Emmes · 11 hours ago

Biostatistician Intern

Emmes Group is transforming the future of clinical research, bringing the promise of new medical discovery closer within reach for patients. The Biostatistics Intern is responsible for working closely with biostatisticians on biomedical research projects across a variety of therapeutic areas.

BiopharmaBiotechnologyClinical TrialsHealth CareMedical
check
H1B Sponsor Likelynote

Responsibilities

Contribute to the review of sample size and other statistical aspects of study design
Perform statistical analysis and prepare summary reports and visualizations
Perform quality control (QC) for statistical deliverables prepared by other staff
Participate in presentations to biomedical investigators or manuscript preparation
Assist with review and finalization of research data sets for statistical analysis

Qualification

SASR programmingStatistical analysisSample size reviewAnalytical skillsPriority managementAttention to detail

Required

Currently enrolled Masters/PhD student in statistics or biostatistics
Excellent analytical/problem solving skills
Strong attention to detail
Ability to manage priorities effectively
Familiarity with SAS or R programming

Benefits

Flexible Approved Time Off
Tuition Reimbursement
401k Retirement Plan
Work From Home Anywhere in the US
Maternal/Paternal Leave
Casual Dress Code & Work Environment

Company

Emmes is a contract research organization that offers clinical research services for public health and biopharmaceutical innovation.

H1B Sponsorship

Emmes has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (8)
2024 (6)
2023 (6)
2022 (11)
2021 (6)
2020 (4)

Funding

Current Stage
Late Stage
Total Funding
unknown
Key Investors
Behrman Capital
2022-06-21Acquired
2019-03-04Private Equity

Leadership Team

leader-logo
Peter Ronco
Chief Executive Officer
linkedin
Company data provided by crunchbase